James Green

Life-Space is betting on a 96 billion CFU probiotic in Asia's booming wellness market. We dive into the science, strategy, and competitive risks.

A new licensing deal for Dickies in Australia reveals a powerful strategy for revitalizing heritage brands through hyper-localized market expertise.

A new technology aims to solve the billion-dollar problem of personalized ads for live sports, potentially reshaping revenue models for broadcasters.

Amid campus crises, Yeshiva University leverages its unique identity to drive record growth, backed by a new health-sciences hub and Israel's President.

A new study touts rapid homebuilding as an economic cure-all, but its corporate backing and ambitious targets raise questions of interest and feasibility.

As NJ prepares for a year-end review of its opioid crisis response, new data reveals a significant drop in overdose deaths, pointing to a strategic shift.

CSU Global's promotion of a student success veteran signals a wider trend in online education: proving student ROI is now the ultimate metric for success.

Government rebates fuel a $3B heat pump market, but high upfront costs and grid limits challenge Canada's ambitious plan to electrify home heating.

Once a niche supplement, MCT oil now drives a billion-dollar industry. But can its volatile supply chain and regulatory hurdles keep pace with demand?

A $150k settlement in a 'phantom vehicle' case reveals how innovative legal tactics are dismantling insurance barriers to post-accident medical recovery.

A new survey shows travelers prefer offsetting carbon to first-class seats, but is this conscious travel trend a real solution or just greenwashing?

Gourmia's new feature-packed air fryer oven lands at Walmart for just $57. Is this a value revolution or a calculated move in the war for countertop space?

A new partnership aims to stop lightning-fast cyberattacks on critical infrastructure, addressing a multi-million dollar vulnerability at the network's edge.

One wallet aims to replace your pen, notebook, and tools. With over $228,000 raised on Kickstarter, is the MultiWallet a productivity marvel or just hype?

University tests show Silanna UV's 235nm LEDs eliminate 99.999% of avian flu virus, promising a safe, continuous disinfection tool for farms and public health.

CytomX heads to key investor conferences with its PROBODY platform. Can promising clinical data and big pharma partnerships overcome recent financial hurdles?

Teva wins key EU approvals for denosumab biosimilars, challenging Amgen's dominance and promising lower costs for osteoporosis and cancer care.

As cyber threats escalate, MSIG USA appoints a new chief to lead its North American expansion. A deep dive into the strategy to capture a booming market.

Facing a cash crunch, Tempest raised up to $8.35M. The deal dilutes shares but buys time for its Phase 3-ready cancer drug and a new CAR-T focus.

A new market report reveals the growing role of a humble seaweed derivative in advanced wound care, drug delivery, and regenerative medicine.